• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医药制造企业智能制造转型路径选择的 NK 模型仿真研究。

NK model simulation study of intelligent manufacturing transformation path selection in pharmaceutical manufacturing enterprises.

机构信息

School of Economics and Management, Jiangxi Polytechnic University, Jiujiang, 332000, China.

Research Center of Management Science and Engineering, Jiangxi Normal University, Nanchang, 330022, China.

出版信息

Sci Rep. 2024 Aug 23;14(1):19646. doi: 10.1038/s41598-024-70502-7.

DOI:10.1038/s41598-024-70502-7
PMID:39179713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11344148/
Abstract

Under the wave of Industry 4.0, traditional pharmaceutical manufacturing enterprises are in urgent need of intelligent manufacturing transformation and upgrading, and exploring the optimal realization path of intelligent manufacturing transformation can help accelerate the transformation process of pharmaceutical manufacturing enterprises. This paper uses grounded theory research methods to conduct a multi-case study to summarize six influencing factors of the intelligent manufacturing transformation of Chinese pharmaceutical manufacturing enterprises; and then analyzes the correlation between the intelligent manufacturing influencing factors based on the DEMATEL method and the NK model, and identifies the key influencing factors according to this, and then draws the fitness landscape map of the intelligent manufacturing transformation, and finally arrives at the optimal path selection of the intelligent manufacturing transformation of pharmaceutical manufacturing enterprises. The study enriches and extends the research paradigm of intelligent manufacturing transformation, and provides lessons for pharmaceutical manufacturing enterprises to realize intelligent manufacturing transformation and upgrading.

摘要

在工业 4.0 的浪潮下,传统制药企业迫切需要智能制造转型升级,探索智能制造转型升级的最优实现路径,有助于加速制药企业的转型升级进程。本文采用扎根理论研究方法,对中国制药企业智能制造转型升级的影响因素进行多案例研究,总结出中国制药企业智能制造转型升级的六大影响因素;然后基于 DEMATEL 方法和 NK 模型对智能制造影响因素进行相关性分析,并据此识别出关键影响因素,进而绘制出智能制造转型升级的适配景观图,最终得出制药企业智能制造转型升级的最优路径选择。该研究丰富和拓展了智能制造转型升级的研究范式,为制药企业实现智能制造转型升级提供了借鉴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/fdc0e5a68f11/41598_2024_70502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/f2babd569e69/41598_2024_70502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/e71edfd3ea88/41598_2024_70502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/762acd44a4d8/41598_2024_70502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/fdc0e5a68f11/41598_2024_70502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/f2babd569e69/41598_2024_70502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/e71edfd3ea88/41598_2024_70502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/762acd44a4d8/41598_2024_70502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7ea/11344148/fdc0e5a68f11/41598_2024_70502_Fig4_HTML.jpg

相似文献

1
NK model simulation study of intelligent manufacturing transformation path selection in pharmaceutical manufacturing enterprises.医药制造企业智能制造转型路径选择的 NK 模型仿真研究。
Sci Rep. 2024 Aug 23;14(1):19646. doi: 10.1038/s41598-024-70502-7.
2
Research on the evolution mechanism of intelligent manufacturing transformation of Chinese pharmaceutical manufacturing enterprises based on system dynamics.基于系统动力学的中国制药企业智能制造转型演化机制研究
Heliyon. 2024 Jul 2;10(13):e33959. doi: 10.1016/j.heliyon.2024.e33959. eCollection 2024 Jul 15.
3
[Construction of theoretical model of traditional Chinese medicine intelligent manufacturing].[中医药智能制造理论模型的构建]
Zhongguo Zhong Yao Za Zhi. 2019 Jul;44(14):3123-3127. doi: 10.19540/j.cnki.cjcmm.20190410.307.
4
Environmental regulations, green innovation and intelligent upgrading of manufacturing enterprises: evidence from China.环境法规、绿色创新与制造业企业智能化升级:来自中国的证据。
Sci Rep. 2020 Sep 2;10(1):14485. doi: 10.1038/s41598-020-71423-x.
5
Research on the Impact Mechanism of Organizational-Based Psychological Ownership on the Intelligent Transformation of Manufacturing Enterprises: Based on the Perspective of Technological Change.基于技术变革视角的组织心理所有权对制造企业智能化转型的影响机制研究
Psychol Res Behav Manag. 2020 Sep 28;13:775-786. doi: 10.2147/PRBM.S264662. eCollection 2020.
6
[Construction of knowledge base of Chinese medicine manufacturing].[中药制造知识库的构建]
Zhongguo Zhong Yao Za Zhi. 2022 Jun;47(12):3402-3408. doi: 10.19540/j.cnki.cjcmm.20220114.601.
7
[Study of intelligent manufacturing quality digitalization of traditional Chinese medicine and practice on Compound Danshen Dripping Pills].[中药智能制造质量数字化研究及复方丹参滴丸实践]
Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(7):1698-1706. doi: 10.19540/j.cnki.cjcmm.20200207.308.
8
Digital finance innovation in green manufacturing: a bibliometric approach.数字金融创新助力绿色制造:文献计量方法
Environ Sci Pollut Res Int. 2023 May;30(22):61340-61368. doi: 10.1007/s11356-021-18016-x. Epub 2022 Jan 14.
9
[Application of process analysis technology in traditional Chinese medicine manufacturing industry].[过程分析技术在中药制造业中的应用]
Zhongguo Zhong Yao Za Zhi. 2024 May;49(9):2299-2307. doi: 10.19540/j.cnki.cjcmm.20231223.303.
10
Collaborative elicitation process for sustainable manufacturing: A novel evolution model of green technology innovation path selection of manufacturing enterprises under environmental regulation.协作启发式可持续制造方法:环境规制下制造企业绿色技术创新路径选择的新型演化模型。
PLoS One. 2022 Jun 10;17(6):e0266169. doi: 10.1371/journal.pone.0266169. eCollection 2022.

本文引用的文献

1
Research on the evolution mechanism of intelligent manufacturing transformation of Chinese pharmaceutical manufacturing enterprises based on system dynamics.基于系统动力学的中国制药企业智能制造转型演化机制研究
Heliyon. 2024 Jul 2;10(13):e33959. doi: 10.1016/j.heliyon.2024.e33959. eCollection 2024 Jul 15.
2
A comprehensive study on Industry 4.0 in the pharmaceutical industry for sustainable development.关于制药行业可持续发展的工业 4.0 的综合研究。
Environ Sci Pollut Res Int. 2023 Aug;30(39):90088-90098. doi: 10.1007/s11356-023-26856-y. Epub 2023 May 2.
3
Direct and spillover portfolio effects of COVID-19.
新冠疫情的直接和溢出投资组合效应
Res Int Bus Finance. 2023 Apr;65:101932. doi: 10.1016/j.ribaf.2023.101932. Epub 2023 Mar 22.
4
Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis.系列:定性研究实用指南。第 3 部分:抽样、数据收集和分析。
Eur J Gen Pract. 2018 Dec;24(1):9-18. doi: 10.1080/13814788.2017.1375091. Epub 2017 Dec 4.
5
Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.50-69 岁患者行主动脉瓣置换术:机械瓣与生物瓣的比较。
Eur Heart J. 2016 Sep 7;37(34):2658-67. doi: 10.1093/eurheartj/ehv580. Epub 2015 Nov 11.
6
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.Ras通路突变在复发性儿童急性淋巴细胞白血病中普遍存在,并赋予对MEK抑制的敏感性。
Blood. 2014 Nov 27;124(23):3420-30. doi: 10.1182/blood-2014-04-531871. Epub 2014 Sep 24.
7
Porous chitosan scaffolds for tissue engineering.用于组织工程的多孔壳聚糖支架
Biomaterials. 1999 Jun;20(12):1133-42. doi: 10.1016/s0142-9612(99)00011-3.
8
Application of finite absorbent Markov chains to sib mating populations with selection.有限吸收马尔可夫链在有选择的同胞交配群体中的应用。
Biometrics. 1969 Mar;25(1):17-26.